Marvel Biosciences Balance Sheet

Financials in millions CAD. Fiscal year is August - July.

Millions CAD. Fiscal year is Aug - Jul.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Jul '25 Jul 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022	Jul '21 Jul 31, 2021
Cash & Equivalents	0.43	0.13	0.35	0.56	0.59	2.39
Cash & Short-Term Investments	0.43	0.13	0.35	0.56	0.59	2.39
Cash Growth	11.77%	-62.73%	-37.88%	-6.17%	-75.21%	964.52%
Other Receivables	0.02	0.17	0.12	0.08	0.06	0.06
Total Trade Receivables	0.02	0.17	0.12	0.08	0.06	0.06
Other Current Assets	0.01	0.03	0.03	0.03	0.26	0.02
Total Current Assets	0.47	0.33	0.49	0.67	0.91	2.47
Net Property, Plant & Equipment	-	-	-	-	-	0
Total Assets	0.47	0.33	0.49	0.67	0.91	2.47
Accounts Payable	1.81	2.02	1.61	1.39	0.72	0.11
Short-Term Debt	0.77	2.31	1.71	-	-	-
Total Current Liabilities	2.58	4.33	3.32	1.39	0.72	0.11
Long-Term Debt	0.62	-	-	-	-	-
Total Long-Term Liabilities	0.62	-	-	-	-	-
Total Liabilities	3.21	4.33	3.32	2.39	0.72	0.11
Common Stock	9.9	8.46	7.58	7.13	6.83	6.46
Additional Paid-in Capital	-	-	-	-	0.12	0.1
Accumulated Other Comprehensive Income	0.48	0.44	0.29	0.2	-	-
Retained Earnings	-13.11	-12.91	-10.7	-9.05	-6.76	-4.2
Shareholders' Equity	-2.73	-4.01	-2.83	-1.72	0.2	2.36
Total Liabilities & Equity	0.47	0.33	0.49	0.67	0.91	2.47
Total Debt	1.4	2.31	1.71	0	0	0
Net Cash (Debt)	-0.96	-2.18	-1.36	0.56	0.59	2.39
Net Cash Growth	-	-	-	-6.17%	-75.21%	964.52%
Net Cash Per Share	-0.02	-0.05	-0.03	0.01	0.02	0.14
Book Value	-2.73	-4.01	-2.83	-1.72	0.2	2.36
Book Value Per Share	-0.05	-0.08	-0.07	-0.04	0.01	0.13
Tangible Book Value	-2.73	-4.01	-2.83	-1.72	0.2	2.36
Tangible Book Value Per Share	-0.05	-0.08	-0.07	-0.04	0.01	0.13